長盈集團(控股)(00689.HK):門多薩省碳氫化合物部門未宣佈其標書中標者的決定
格隆匯 12 月 14日丨長盈集團(控股)(00689.HK)發佈公告,有關(其中包括)建議收購Chañares油田開採權。如此前通函所述,根據門多薩省碳氫化合物部門發佈的招標程序的最新通告,標書中標者的決定將於2020年11月29日至12月11日期間(阿根廷時間)宣佈。
由於集團於提交標書後向門多薩省碳氫化合物部門提供額外資料,2020年11月27日(阿根廷時間),門多薩省碳氫化合物部門發佈一份暫停開啟投標者商業標書的通知,並表示開標暫停直至對集團提供的額外資料完成稽查。2020年12月11日(阿根廷時間),門多薩省碳氫化合物部門並沒有宣佈其標書中標者的決定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.